Bank Hapoalim BM’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $518K | Buy |
5,005
+359
| +8% | +$32K | 0.03% | 83 |
|
|
2026
Q1 | $334K | Buy |
4,646
+331
| +8% | +$25.5K | 0.05% | 92 |
|
|
2025
Q4 | $342K | Buy |
4,315
+50
| +1% | +$3.94K | 0.03% | 89 |
|
|
2025
Q3 | $322K | Buy |
4,265
+345
| +9% | +$23.6K | 0.04% | 100 |
|
|
2025
Q2 | $270K | Sell |
3,920
-55
| -1% | -$3.61K | 0.04% | 111 |
|
|
2025
Q1 | $269K | Buy |
+3,975
| New | +$238K | 0.04% | 111 |
|
|
2024
Q2 | – | Sell |
-4,362
| Closed | -$348K | – | 138 |
|
|
2024
Q1 | $348K | Sell |
4,362
-224
| -5% | -$17.1K | 0.05% | 120 |
|
|
2023
Q4 | $362K | Sell |
4,586
-900
| -16% | -$64.1K | 0.05% | 125 |
|
|
2023
Q3 | $383K | Sell |
5,486
-2,191
| -29% | -$155K | 0.06% | 112 |
|
|
2023
Q2 | $531K | Sell |
7,677
-3,234
| -30% | -$230K | 0.08% | 124 |
|
|
2023
Q1 | $811K | Buy |
10,911
+5,819
| +114% | +$488K | 0.11% | 114 |
|
|
2022
Q4 | $475K | Sell |
5,092
-360
| -7% | -$34.7K | 0.06% | 138 |
|
|
2022
Q3 | $520K | Sell |
5,452
-386
| -7% | -$38.2K | 0.07% | 136 |
|
|
2022
Q2 | $541K | Sell |
5,838
-720
| -11% | -$70.3K | 0.07% | 145 |
|
|
2022
Q1 | $664K | Sell |
6,558
-746
| -10% | -$78.4K | 0.07% | 148 |
|
|
2021
Q4 | $753K | Sell |
7,304
-805
| -10% | -$74.4K | 0.08% | 146 |
|
|
2021
Q3 | $688K | Sell |
8,109
-2,755
| -25% | -$231K | 0.07% | 147 |
|
|
2021
Q2 | $906K | Sell |
10,864
-886
| -8% | -$72.6K | 0.1% | 136 |
|
|
2021
Q1 | $884K | Buy |
11,750
+767
| +7% | +$55.9K | 0.11% | 124 |
|
|
2020
Q4 | $750K | Buy |
10,983
+1,378
| +14% | +$89.6K | 0.1% | 118 |
|
|
2020
Q3 | $561K | Sell |
9,605
-14,538
| -60% | -$905K | 0.03% | 111 |
|
|
2020
Q2 | $1.57M | Buy |
24,143
+2,000
| +9% | +$126K | 0.37% | 60 |
|
|
2020
Q1 | $1.31M | Sell |
22,143
-5,807
| -21% | -$388K | 0.41% | 56 |
|
|
2019
Q4 | $2.08M | Buy |
27,950
+550
| +2% | +$38.6K | 0.46% | 46 |
|
|
2019
Q3 | $1.7M | Buy |
27,400
+2,896
| +12% | +$172K | 0.42% | 48 |
|
|
2019
Q2 | $1.33M | Buy |
24,504
+4,684
| +24% | +$252K | 0.33% | 56 |
|
|
2019
Q1 | $1.07M | Buy |
+19,820
| New | +$1.22M | 0.26% | 65 |
|
|
2017
Q4 | – | Sell |
-14,832
| Closed | -$1.21M | – | 205 |
|
|
2017
Q3 | $1.21M | Sell |
14,832
-3,628
| -20% | -$287K | 0.27% | 73 |
|
|
2017
Q2 | $1.49M | Sell |
18,460
-3,850
| -17% | -$304K | 0.35% | 59 |
|
|
2017
Q1 | $1.75M | Sell |
22,310
-289
| -1% | -$23.1K | 0.41% | 53 |
|
|
2016
Q4 | $1.78M | Sell |
22,599
-6,009
| -21% | -$486K | 0.48% | 50 |
|
|
2016
Q3 | $2.54M | Buy |
28,608
+935
| +3% | +$88.3K | 0.6% | 39 |
|
|
2016
Q2 | $2.65M | Buy |
27,673
+3,995
| +17% | +$398K | 0.62% | 43 |
|
|
2016
Q1 | $2.46M | Buy |
23,678
+3,624
| +18% | +$352K | 0.58% | 40 |
|
|
2015
Q4 | $1.96M | Buy |
20,054
+4,148
| +26% | +$406K | 0.45% | 45 |
|
|
2015
Q3 | $1.53M | Sell |
15,906
-1,673
| -10% | -$176K | 0.36% | 53 |
|
|
2015
Q2 | $1.84M | Sell |
17,579
-927
| -5% | -$94.7K | 0.36% | 55 |
|
|
2015
Q1 | $1.91M | Sell |
18,506
-3,253
| -15% | -$329K | 0.35% | 58 |
|
|
2014
Q4 | $2.1M | Sell |
21,759
-801
| -4% | -$70.6K | 0.45% | 52 |
|
|
2014
Q3 | $1.79M | Sell |
22,560
-1,247
| -5% | -$98.3K | 0.42% | 52 |
|
|
2014
Q2 | $1.79M | Sell |
23,807
-4,354
| -15% | -$329K | 0.44% | 45 |
|
|
2014
Q1 | $2.1M | Buy |
28,161
+1,341
| +5% | +$94.7K | 0.57% | 34 |
|
|
2013
Q4 | $1.92M | Buy |
+26,820
| New | +$1.72M | 0.59% | 42 |
|
Other funds holding CVS
Bank Hapoalim BM's CVS Position: Q2 2026 in Review
Bank Hapoalim BM increased its CVS Health (CVS) stake by 7.7% in Q2 2026, buying an estimated $32K and bringing the position to 5,005 shares worth $518K. The position accounts for 0.03% of the portfolio, ranked #83.
Bank Hapoalim BM first reported a position in CVS in Q4 2013 and has held it in 43 quarters since. The position peaked at $2.65M in Q2 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Bank Hapoalim BM held 5,005 shares of CVS Health worth $518K as of Q2 2026.
- Bank Hapoalim BM bought 359 CVS Health shares in Q2 2026, an estimated $32K.
- CVS Health made up 0.03% of Bank Hapoalim BM's portfolio in Q2 2026, its #83 holding.
- Bank Hapoalim BM first reported a position in CVS Health in Q4 2013 and has held it in 43 quarters since.
- Bank Hapoalim BM's CVS Health position peaked at $2.65M in Q2 2016.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Bank Hapoalim BM's 13F filing for Q2 2026, filed 5 Aug 2026.